{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-040192","form_type":"8-K","ticker":"ACRS","cik":"0001557746","company_name":"Aclaris Therapeutics, Inc.","filed_at":"2023-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.562231+00:00","generated_at":"2026-06-17T07:51:43.168095+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Aclaris raises $27.5M via sale of 3.4M shares to Bain Capital affiliates","bullets":["Sold 3.4M shares of common stock for aggregate gross proceeds of $27.5M.","Shares purchased by entities affiliated with Bain Capital Life Sciences.","Sale executed under existing ATM agreement with SVB Securities and Cantor Fitzgerald."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-040192","json":"https://secwatch.observer/filing/0001104659-23-040192.json","markdown":"https://secwatch.observer/filing/0001104659-23-040192.md","text":"https://secwatch.observer/filing/0001104659-23-040192.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1557746/000110465923040192/0001104659-23-040192-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1557746/000110465923040192/tm2311197d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T07:51:43.168095+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}